{"version":"1.0","provider_name":"FYB Financial Yearbook","provider_url":"https:\/\/www.fyb.de\/en\/","author_name":"Tatjana Anderer","author_url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/","title":"Labquality Oy acquires P.R.I.S.M.A.-CRO Clinical Research Organization - FYB Financial Yearbook","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XKxyHKghsz\"><a href=\"https:\/\/www.fyb.de\/en\/labquality-oy-acquires-p-r-i-s-m-a-cro-clinical-research-organization\/\">Labquality Oy acquires P.R.I.S.M.A.-CRO Clinical Research Organization<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fyb.de\/en\/labquality-oy-acquires-p-r-i-s-m-a-cro-clinical-research-organization\/embed\/#?secret=XKxyHKghsz\" width=\"600\" height=\"338\" title=\"&#8220;Labquality Oy acquires P.R.I.S.M.A.-CRO Clinical Research Organization&#8221; &#8212; FYB Financial Yearbook\" data-secret=\"XKxyHKghsz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2023\/10\/caroline-frohnwieser-heuking.jpg","thumbnail_width":474,"thumbnail_height":474,"description":"Helsinki\/ Langen\u00adfeld \u2014 Labqua\u00adlity Oy acqui\u00adres P.R.I.S.M.A.-CRO Clini\u00adcal Rese\u00adarch Orga\u00adniza\u00adtion. P.R.I.S.M.A. is a German company specia\u00adli\u00adzing in clini\u00adcal trial services for the phar\u00admaceu\u00adti\u00adcal and biotech indus\u00adtries. P.R.I.S.M.A. and its expe\u00adri\u00aden\u00adced profes\u00adsio\u00adnals streng\u00adthen Labqua\u00adli\u00adty\u2019s offer of clini\u00adcal trials in the phar\u00admaceu\u00adti\u00adcal and biotech markets. The acqui\u00adsi\u00adtion is in line with Labqua\u00adli\u00adty\u2019s stra\u00adtegy to build a full-service [&hellip;]"}